Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review

Abstract

Reviany V. Nidom, Arif N. M. Ansori, Setyarina Indrasari, Irine Normalina, Muhammad K. J. Kusala, Asep Saefuddin, Chairul A. Nidom.

SARS-CoV-2 firstly emerged in China and sporadically transmitted worldwide. In March 2020, WHO announced that the infection was a pandemic. The outbreak and rapid transmission of COVID-19 have endangered the global health and the economy. This crisis has called for an extensive scientific mobilization of studies on SARS-CoV-2 concerning its clinical aspects, characteristics, and its mechanism of transmission. Although many scientists have published the treatment options against COVID-19, currently, there is not any approved medications against the virus yet. COVID-19 vaccine development has started in many research centers and pharmaceutical industries following the announcement of the agent and the full genome of SARS-CoV-2 recognized. Recently, the collected data described that COVID-19 vaccine candidates grouped into the following types: protein-based, epitope, inactivated or live-attenuated virus, virus-like particle, nucleic acid-based, and viral vectors. Therefore, the present review gives a sneak peek of recent updates on COVID-19 vaccine construction worldwide and COVID-19 vaccine’s acceptance in Indonesia.

How to Cite this Article
Pubmed Style

Nidom RV, Ansori ANM, Indrasari S, Normalina I, Kusala MKJ, Saefuddin A, Nidom CA. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. SRP. 2020; 11(10): 807-818.
doi:10.31838/srp.2020.10.121

Web Style

Nidom RV, Ansori ANM, Indrasari S, Normalina I, Kusala MKJ, Saefuddin A, Nidom CA. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. http://www.sysrevpharm.org/?mno=14123 [Access: March 29, 2021]. doi:10.31838/srp.2020.10.121

AMA (American Medical Association) Style

Nidom RV, Ansori ANM, Indrasari S, Normalina I, Kusala MKJ, Saefuddin A, Nidom CA. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. SRP. 2020; 11(10): 807-818. doi:10.31838/srp.2020.10.121



Vancouver/ICMJE Style

Nidom RV, Ansori ANM, Indrasari S, Normalina I, Kusala MKJ, Saefuddin A, Nidom CA. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. SRP. (2020), [cited March 29, 2021]; 11(10): 807-818. doi:10.31838/srp.2020.10.121



Harvard Style

Nidom, R. V., Ansori, . A. N. M., Indrasari, . S., Normalina, . I., Kusala, . M. K. J., Saefuddin, . A. & Nidom, . C. A. (2020) Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. SRP, 11 (10), 807-818. doi:10.31838/srp.2020.10.121



Turabian Style

Nidom, Reviany V., Arif N. M. Ansori, Setyarina Indrasari, Irine Normalina, Muhammad K. J. Kusala, Asep Saefuddin, and Chairul A. Nidom. 2020. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. Systematic Reviews in Pharmacy, 11 (10), 807-818. doi:10.31838/srp.2020.10.121



Chicago Style

Nidom, Reviany V., Arif N. M. Ansori, Setyarina Indrasari, Irine Normalina, Muhammad K. J. Kusala, Asep Saefuddin, and Chairul A. Nidom. "Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review." Systematic Reviews in Pharmacy 11 (2020), 807-818. doi:10.31838/srp.2020.10.121



MLA (The Modern Language Association) Style

Nidom, Reviany V., Arif N. M. Ansori, Setyarina Indrasari, Irine Normalina, Muhammad K. J. Kusala, Asep Saefuddin, and Chairul A. Nidom. "Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review." Systematic Reviews in Pharmacy 11.10 (2020), 807-818. Print. doi:10.31838/srp.2020.10.121



APA (American Psychological Association) Style

Nidom, R. V., Ansori, . A. N. M., Indrasari, . S., Normalina, . I., Kusala, . M. K. J., Saefuddin, . A. & Nidom, . C. A. (2020) Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. Systematic Reviews in Pharmacy, 11 (10), 807-818. doi:10.31838/srp.2020.10.121

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3